ATE101522T1 - Verfahren zur vorbeugung einer von blutplaettchen abhaengigen gefaessthrombose. - Google Patents

Verfahren zur vorbeugung einer von blutplaettchen abhaengigen gefaessthrombose.

Info

Publication number
ATE101522T1
ATE101522T1 AT89903538T AT89903538T ATE101522T1 AT E101522 T1 ATE101522 T1 AT E101522T1 AT 89903538 T AT89903538 T AT 89903538T AT 89903538 T AT89903538 T AT 89903538T AT E101522 T1 ATE101522 T1 AT E101522T1
Authority
AT
Austria
Prior art keywords
procedures
vascular thrombosis
prevent platelet
platelet dependent
dependent vascular
Prior art date
Application number
AT89903538T
Other languages
English (en)
Inventor
Laurence A Harker
Stephen R Hanson
Original Assignee
Scripps Clinic Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic Res filed Critical Scripps Clinic Res
Application granted granted Critical
Publication of ATE101522T1 publication Critical patent/ATE101522T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT89903538T 1987-11-25 1989-06-22 Verfahren zur vorbeugung einer von blutplaettchen abhaengigen gefaessthrombose. ATE101522T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US12517887A 1987-11-25 1987-11-25
US07/275,330 US4929602A (en) 1987-11-25 1988-11-22 Method of inhibiting platelet dependent arterial thrombosis
PCT/US1988/004210 WO1989005148A1 (en) 1987-11-25 1988-11-23 A method of inhibiting platelet dependent arterial thrombosis
EP89903538A EP0343241B1 (de) 1987-11-25 1989-06-22 Verfahren zur vorbeugung einer von blutplättchen abhängigen gefässthrombose

Publications (1)

Publication Number Publication Date
ATE101522T1 true ATE101522T1 (de) 1994-03-15

Family

ID=26823342

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89903538T ATE101522T1 (de) 1987-11-25 1989-06-22 Verfahren zur vorbeugung einer von blutplaettchen abhaengigen gefaessthrombose.

Country Status (8)

Country Link
US (1) US4929602A (de)
EP (1) EP0343241B1 (de)
JP (1) JP2758953B2 (de)
AT (1) ATE101522T1 (de)
AU (1) AU599280B2 (de)
CA (1) CA1335075C (de)
DE (1) DE3887875T2 (de)
WO (1) WO1989005148A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084274A (en) * 1987-11-17 1992-01-28 Scripps Clinic And Research Foundation Inhibition of arterial thrombotic occlusion or thromboembolism
US5637575A (en) * 1988-01-19 1997-06-10 The Trustees Of The University Of Pennsylvania Methods of inhibiting restenosis
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5658894A (en) * 1989-04-23 1997-08-19 The Trustees Of The University Of Pennsylvania Compositions for inhibiting restenosis
US5204323B1 (en) * 1988-10-06 1995-07-18 Ciba Geigy Corp Hirudin antidotal compositions and methods
US5354770A (en) * 1989-02-27 1994-10-11 Daiichi Pharmaceutical Co., Ltd. Using imidazolyl tetrahydronaphthalene carboxylic acids to inhibit restenosis
US6146358A (en) * 1989-03-14 2000-11-14 Cordis Corporation Method and apparatus for delivery of therapeutic agent
US5242397A (en) * 1989-06-20 1993-09-07 Cedars-Sinai Medical Center Catheter device and method of use for intramural delivery of protein kinase C and tyrosine protein kinase inhibitors to prevent restenosis after balloon angioplasty
US5192747A (en) * 1989-10-03 1993-03-09 Merrell Dow Pharmaceuticals Inc. Anticoagulant peptides
US5264420A (en) * 1990-09-27 1993-11-23 Merck & Co., Inc. Fibrinogen receptor antagonists
GB9024129D0 (en) * 1990-11-06 1990-12-19 Thrombosis Research Trust Inhibitors and substrates of thrombin
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
US5990095A (en) 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5811447A (en) * 1993-01-28 1998-09-22 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6515009B1 (en) 1991-09-27 2003-02-04 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US5383928A (en) * 1992-06-10 1995-01-24 Emory University Stent sheath for local drug delivery
FR2695562B1 (fr) * 1992-09-11 1994-10-14 Synthelabo Utilisation d'un inhibiteur direct de la thrombine pour la fabrication d'un médicament à activité thrombolytique.
US6387881B1 (en) 1992-09-19 2002-05-14 Trigen Ltd Inhibitors and substrates of thrombin
US6251920B1 (en) 1993-05-13 2001-06-26 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US5770609A (en) * 1993-01-28 1998-06-23 Neorx Corporation Prevention and treatment of cardiovascular pathologies
US6395494B1 (en) 1993-05-13 2002-05-28 Neorx Corporation Method to determine TGF-β
US6306421B1 (en) 1992-09-25 2001-10-23 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP1826280A3 (de) 1992-09-25 2007-12-05 Boston Scientific Limited Therapeutische Konjugate zum Hemmen von glatten Gefäßmuskelzellen
US5595722A (en) * 1993-01-28 1997-01-21 Neorx Corporation Method for identifying an agent which increases TGF-beta levels
US6491938B2 (en) 1993-05-13 2002-12-10 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
EP1447098A3 (de) 1993-01-28 2005-06-29 Boston Scientific Limited Therapeutische Inhibitoren der glatten Gefässmuskulaturzellen
US5981568A (en) 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
US6663881B2 (en) 1993-01-28 2003-12-16 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CA2162586C (en) * 1993-05-13 2006-01-03 David J. Grainger Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
US6197789B1 (en) 1995-06-07 2001-03-06 Neorx Corporation Prevention and treatment of cardiovascular pathologies with tamoxifen analogues
US5639726A (en) * 1994-09-30 1997-06-17 The Regents Of The University Of Michigan Peptide mediated enhancement of thrombolysis methods and compositions
US5643580A (en) * 1994-10-17 1997-07-01 Surface Genesis, Inc. Biocompatible coating, medical device using the same and methods
US5730698A (en) * 1995-05-09 1998-03-24 Fischell; Robert E. Balloon expandable temporary radioisotope stent system
US7611533B2 (en) * 1995-06-07 2009-11-03 Cook Incorporated Coated implantable medical device
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
CA2285389C (en) 1997-03-31 2008-12-30 Neorx Corporation Use of cytoskeletal inhibitors for the prevention of restenosis
US6458590B1 (en) 1997-08-07 2002-10-01 The United States Of America, As Represented By The Department Of Health And Human Services Methods and compositions for treatment of restenosis
US6187038B1 (en) 1998-04-08 2001-02-13 Sulzer Carbomedics Inc. Small bore biologic graft with therapeutic delivery system
US6613083B2 (en) 2001-05-02 2003-09-02 Eckhard Alt Stent device and method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US431890A (en) * 1890-07-08 Tool for extracting drill-rods
US4318904A (en) * 1980-04-25 1982-03-09 Research Corporation Peptide affinity labels for thrombin and other trypsin-like proteases
DE3505555A1 (de) * 1985-02-18 1986-09-11 Behringwerke Ag, 3550 Marburg Neue oligopeptidylargininolderivate und deren homologe, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel

Also Published As

Publication number Publication date
EP0343241A1 (de) 1989-11-29
DE3887875D1 (de) 1994-03-24
DE3887875T2 (de) 1994-08-18
AU599280B2 (en) 1990-07-12
CA1335075C (en) 1995-04-04
JP2758953B2 (ja) 1998-05-28
EP0343241A4 (en) 1991-07-31
EP0343241B1 (de) 1994-02-16
JPH04501848A (ja) 1992-04-02
US4929602A (en) 1990-05-29
WO1989005148A1 (en) 1989-06-15
AU3286489A (en) 1989-07-05

Similar Documents

Publication Publication Date Title
ATE101522T1 (de) Verfahren zur vorbeugung einer von blutplaettchen abhaengigen gefaessthrombose.
DE59101695D1 (de) Verfahren zur Erzeugung von niederen Olefinen.
DE3777417D1 (de) Verfahren zur kryokonservierung von herzklappen.
DE3886710D1 (de) Verfahren zur selektiven inhibierung von hiv.
DE69008820D1 (de) Verfahren zur Behandlung von Polymerisaten.
DE59103750D1 (de) Verfahren zur teilweisen elektrolytischen Enthalogenierung von Di-und Trichloressigsäure sowie Elektrolyselösung.
DE3788742D1 (de) Verfahren zur Herstellung von Blockcopolymeren.
DE68916130D1 (de) Verfahren zur Herstellung von Block-copolyamid.
DE69007993D1 (de) Verfahren zur Wiedergewinnung von Bromwasserstoffsäure und Methanol.
DE68921870D1 (de) Verfahren zur Reduktion von Stickoxiden.
DE59404520D1 (de) Verfahren zur Hydroformylierung von Butadien-1.3
DE69202115D1 (de) Verfahren zur Darstellung von 1,2-Naphtho-Chinondiazido-5-Sulfonylchlorid.
DE68921582D1 (de) Verfahren zur Herstellung von funktionellen Isothiocyanatometallkomplexen.
DE58906613D1 (de) Verfahren zur Herstellung von orthodontischen Teilen.
DE3883645D1 (de) Therapeutische Zusamensetzungen und Verfahren zur Verhinderung von Fibrinablagerung und Adhäsionen.
DE69103021D1 (de) Verfahren zur verminderung des reissens von laufendem garn.
ATE84317T1 (de) Verfahren zur reduktion von ketonen.
DE59006645D1 (de) Verfahren zur kontinuierlichen herstellung von 3,3'-dichlor-benzidin-dihidrochlorid.
DE3885818D1 (de) Trinatriumsalz des 2,4,6-Trimercapto-s-triazin-nonahydrats und Verfahren zur Herstellung.
DE69207648D1 (de) Verfahren zur Herstellung von Pfropfcopolymeren
DE58901165D1 (de) Verfahren zur herstellung von 2,4-dihydroxybenzoesaeure.
DE68905393D1 (de) Verfahren zur oxydierung von ungesaettigten aromatischen verbindungen.
DE59309002D1 (de) Verfahren zur Herstellung von 6-Chlor-(6H)-dibenz-(c,e)(1,2)-oxaphosphorin
DE68911603D1 (de) Verfahren zur Herstellung von 2-Pyrrolidon.
DE3781279D1 (de) Verfahren zur behandlung von blut.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time